Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.

Toyoda H, Kumada T, Tada T, Niinomi T, Ito T, Sone Y, Kaneoka Y, Maeda A.

J Hepatol. 2013 Jun;58(6):1174-80. doi: 10.1016/j.jhep.2013.01.030. Epub 2013 Jan 29.

PMID:
23376360
2.

Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.

Toyoda H, Kumada T, Tada T, Sone Y, Maeda A, Kaneoka Y.

Hepatol Int. 2015 Jan;9(1):84-92. doi: 10.1007/s12072-014-9553-5. Epub 2014 Jul 23.

PMID:
25788383
3.

Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.

Lee DH, Lee JM, Lee JY, Kim SH, Kim JH, Yoon JH, Kim YJ, Lee JH, Yu SJ, Han JK, Choi BI.

J Hepatol. 2015 May;62(5):1122-30. doi: 10.1016/j.jhep.2014.12.015. Epub 2014 Dec 18.

PMID:
25529623
4.

Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.

Inoue M, Ogasawara S, Chiba T, Ooka Y, Wakamatsu T, Kobayashi K, Suzuki E, Tawada A, Yokosuka O.

J Gastroenterol Hepatol. 2017 Apr;32(4):908-915. doi: 10.1111/jgh.13622.

PMID:
27787908
5.

Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.

Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.

J Gastroenterol. 2012 Sep;47(9):1036-47. doi: 10.1007/s00535-012-0571-6. Epub 2012 Apr 17.

PMID:
22526270
6.

Hypointense hepatocellular nodules on hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI: can increasing the flip angle improve conspicuity of lesions?

Tamada T, Ito K, Yamamoto A, Yasokawa K, Higaki A, Kanki A, Sato T, Tanimoto D, Higashi H.

J Magn Reson Imaging. 2013 May;37(5):1093-9. doi: 10.1002/jmri.23903. Epub 2012 Nov 12.

PMID:
23148032
7.
8.

Relationship between signal intensity on hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MR imaging and prognosis of borderline lesions of hepatocellular carcinoma.

Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A.

Eur J Radiol. 2012 Nov;81(11):3002-9. doi: 10.1016/j.ejrad.2012.03.029. Epub 2012 Jun 29.

PMID:
22748558
9.
10.

Risk of hypervascularization in small hypovascular hepatic nodules showing hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease.

Takechi M, Tsuda T, Yoshioka S, Murata S, Tanaka H, Hirooka M, Mochizuki T.

Jpn J Radiol. 2012 Nov;30(9):743-51. doi: 10.1007/s11604-012-0120-5. Epub 2012 Sep 22.

PMID:
23001373
11.

Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study.

Granito A, Galassi M, Piscaglia F, Romanini L, Lucidi V, Renzulli M, Borghi A, Grazioli L, Golfieri R, Bolondi L.

Aliment Pharmacol Ther. 2013 Feb;37(3):355-63. doi: 10.1111/apt.12166. Epub 2012 Dec 2.

12.

Hypovascular hepatic nodules showing hypointense on the hepatobiliary-phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: a nationwide retrospective study on their natural course and risk factors.

Inoue T, Hyodo T, Murakami T, Takayama Y, Nishie A, Higaki A, Korenaga K, Sakamoto A, Osaki Y, Aikata H, Chayama K, Suda T, Takano T, Miyoshi K, Koda M, Numata K, Tanaka H, Iijima H, Ochi H, Hirooka M, Imai Y, Kudo M.

Dig Dis. 2013;31(5-6):472-9. doi: 10.1159/000355248. Epub 2013 Nov 21.

13.

Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.

Saito K, Kotake F, Ito N, Ozuki T, Mikami R, Abe K, Shimazaki Y.

Magn Reson Med Sci. 2005;4(1):1-9.

14.

Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.

Matsuda M, Tsuda T, Yoshioka S, Murata S, Tanaka H, Hirooka M, Hiasa Y, Mochizuki T.

Jpn J Radiol. 2014 Jul;32(7):405-13. doi: 10.1007/s11604-014-0323-z. Epub 2014 May 24.

PMID:
24854900
15.

Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging.

Akai H, Matsuda I, Kiryu S, Tajima T, Takao H, Watanabe Y, Imamura H, Kokudo N, Akahane M, Ohtomo K.

Eur J Radiol. 2012 Nov;81(11):2973-7. doi: 10.1016/j.ejrad.2012.01.007. Epub 2012 Jan 26.

PMID:
22280873
16.

Intranodular signal intensity analysis of hypovascular high-risk borderline lesions of HCC that illustrate multi-step hepatocarcinogenesis within the nodule on Gd-EOB-DTPA-enhanced MRI.

Kobayashi S, Matsui O, Gabata T, Koda W, Minami T, Ryu Y, Kozaka K, Kitao A.

Eur J Radiol. 2012 Dec;81(12):3839-45. doi: 10.1016/j.ejrad.2012.06.027. Epub 2012 Aug 10.

PMID:
22884705
17.

Comparison between areas with Gd-EOB-DTPA uptake and without in hepatocellular carcinomas on Gd-EOB-DTPA-enhanced hepatobiliary-phase MR imaging: pathological correlation.

Lee S, Kim SH, Park CK, Kim YS, Lee WJ, Lim HK.

J Magn Reson Imaging. 2010 Sep;32(3):719-25. doi: 10.1002/jmri.22291.

PMID:
20815073
18.

Prognosis of small hepatocellular nodules detected only at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MR imaging as hypointensity in cirrhosis or chronic hepatitis.

Higaki A, Ito K, Tamada T, Sone T, Kanki A, Noda Y, Yasokawa K, Yamamoto A.

Eur Radiol. 2014 Oct;24(10):2476-81. doi: 10.1007/s00330-014-3293-8. Epub 2014 Jul 17.

PMID:
25030460
19.

Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.

Korkusuz H, Knau LL, Kromen W, Bihrer V, Keese D, Piiper A, Vogl TJ.

J Magn Reson Imaging. 2012 Jun;35(6):1397-402. doi: 10.1002/jmri.23584. Epub 2012 Jan 20.

PMID:
22267126
20.

MR imaging of carcinosarcoma of the liver using Gd-EOB-DTPA.

Yasutake T, Kiryu S, Akai H, Watadani T, Akahane M, Tomizawa N, Gonoi W, Ikemura M, Takahashi M, Matsuoka Y, Ohtomo K.

Magn Reson Med Sci. 2014;13(2):117-21. Epub 2014 Apr 28.

Supplemental Content

Support Center